dalteparin has been researched along with Atherosclerosis in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atherosclerosis is characterized by a proliferation of vascular smooth muscle cells (VSMCs) and their migration to the intima, which induces thickening of the intima itself, but the mechanism remains poorly understood." | 1.43 | Role of parnaparin in atherosclerosis. ( Artico, M; Bonomini, F; Parnigotto, P; Rezzani, R; Rodella, LF; Taurone, S; Zamai, L, 2016) |
| "Dalteparin may inhibit atherosclerotic lesions by downregulating the expression of LOX-1 protein." | 1.42 | Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice. ( Bao, H; Chen, D; Li, W; Miao, Y; Su, L; Yan, Z; Zhang, Q, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuz'min, VV | 1 |
| Tsaregorodtseva, NA | 1 |
| Iurchenko, LN | 1 |
| Bonomini, F | 1 |
| Taurone, S | 1 |
| Parnigotto, P | 1 |
| Zamai, L | 1 |
| Rodella, LF | 1 |
| Artico, M | 1 |
| Rezzani, R | 1 |
| Naumnik, B | 1 |
| Koc-Żórawska, E | 1 |
| Myśliwiec, M | 1 |
| Deepa, PR | 1 |
| Varalakshmi, P | 1 |
| Su, L | 1 |
| Zhang, Q | 1 |
| Bao, H | 1 |
| Li, W | 1 |
| Miao, Y | 1 |
| Yan, Z | 1 |
| Chen, D | 1 |
1 trial available for dalteparin and Atherosclerosis
| Article | Year |
|---|---|
Over-dialysis plasma RANTES increase depends on heparin dose and cardiovascular disease status.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Appointments and Schedules; Atherosclerosis; Chemoki | 2013 |
4 other studies available for dalteparin and Atherosclerosis
| Article | Year |
|---|---|
[Activation of intravascular microcoagulation of blood in patients with atherosclerotic gangrene of the lower limbs].
Topics: Aged; Aged, 80 and over; Anticoagulants; Atherosclerosis; Female; Gangrene; Humans; Lower Extremity; | 2008 |
Role of parnaparin in atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Disease Models, Animal; Heparin, Lo | 2016 |
Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative.
Topics: Animals; Anticoagulants; Atherosclerosis; Biomarkers; Blood Proteins; Disease Models, Animal; Hepari | 2006 |
Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Dalteparin; Down-Regulation; Mice; Mice, Knockout; Plaq | 2015 |